These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 23688984)

  • 41. SRG3/mBAF155 stabilizes the SWI/SNF-like BAF complex by blocking CHFR mediated ubiquitination and degradation of its major components.
    Jung I; Sohn DH; Choi J; Kim JM; Jeon S; Seol JH; Seong RH
    Biochem Biophys Res Commun; 2012 Feb; 418(3):512-7. PubMed ID: 22285184
    [TBL] [Abstract][Full Text] [Related]  

  • 42. SWI/SNF Complex-deficient Undifferentiated/Rhabdoid Carcinomas of the Gastrointestinal Tract: A Series of 13 Cases Highlighting Mutually Exclusive Loss of SMARCA4 and SMARCA2 and Frequent Co-inactivation of SMARCB1 and SMARCA2.
    Agaimy A; Daum O; Märkl B; Lichtmannegger I; Michal M; Hartmann A
    Am J Surg Pathol; 2016 Apr; 40(4):544-53. PubMed ID: 26551623
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Loss of the epigenetic tumor suppressor SNF5 leads to cancer without genomic instability.
    McKenna ES; Sansam CG; Cho YJ; Greulich H; Evans JA; Thom CS; Moreau LA; Biegel JA; Pomeroy SL; Roberts CW
    Mol Cell Biol; 2008 Oct; 28(20):6223-33. PubMed ID: 18710953
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The SWI/SNF complex and cancer.
    Reisman D; Glaros S; Thompson EA
    Oncogene; 2009 Apr; 28(14):1653-68. PubMed ID: 19234488
    [TBL] [Abstract][Full Text] [Related]  

  • 45. SMARCB1 Deficiency Integrates Epigenetic Signals to Oncogenic Gene Expression Program Maintenance in Human Acute Myeloid Leukemia.
    Chatterjee SS; Biswas M; Boila LD; Banerjee D; Sengupta A
    Mol Cancer Res; 2018 May; 16(5):791-804. PubMed ID: 29483235
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Modulating the Expression Strength of the Baculovirus/Insect Cell Expression System: A Toolbox Applied to the Human Tumor Suppressor SMARCB1/SNF5.
    Golas MM; Jayaprakash S; Le LTM; Zhao Z; Heras Huertas V; Jensen IS; Yuan J; Sander B
    Mol Biotechnol; 2018 Nov; 60(11):820-832. PubMed ID: 30178299
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Loss of the INI1 tumor suppressor does not impair the expression of multiple BRG1-dependent genes or the assembly of SWI/SNF enzymes.
    Doan DN; Veal TM; Yan Z; Wang W; Jones SN; Imbalzano AN
    Oncogene; 2004 Apr; 23(19):3462-73. PubMed ID: 14990991
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Knock down of hSNF5/Ini1 causes cell cycle arrest and apoptosis in a p53-dependent manner.
    Kato H; Honma R; Sanda T; Fujiwara T; Ito E; Yanagisawa Y; Imai J; Okamoto T; Watanabe S
    Biochem Biophys Res Commun; 2007 Sep; 361(3):580-5. PubMed ID: 17669367
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Chromatin remodeling defects and cancer: the SWI/SNF example].
    Bourdeaut F; Bièche I
    Bull Cancer; 2012 Dec; 99(12):1133-40. PubMed ID: 23222069
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Knockdown of DEPTOR inhibits cell proliferation and increases chemosensitivity to melphalan in human multiple myeloma RPMI-8226 cells via inhibiting PI3K/AKT activity.
    Zhang HR; Chen JM; Zeng ZY; Que WZ
    J Int Med Res; 2013 Jun; 41(3):584-95. PubMed ID: 23613505
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Round-spotted pufferfish (Tetraodon fluviatilis) snf5 gene is oriented in a tail-to-tail manner with the set gene which encodes an inhibitor of protein phosphatase 2A.
    Yao CW; Leu JH; Chin C; Chou CK; Huang CJ
    DNA Cell Biol; 1998 Jan; 17(1):69-82. PubMed ID: 9468224
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The BRG1- and hBRM-associated factor BAF57 induces apoptosis by stimulating expression of the cylindromatosis tumor suppressor gene.
    Wang L; Baiocchi RA; Pal S; Mosialos G; Caligiuri M; Sif S
    Mol Cell Biol; 2005 Sep; 25(18):7953-65. PubMed ID: 16135788
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Bruton's tyrosine kinase (Btk) enhances transcriptional co-activation activity of BAM11, a Btk-associated molecule of a subunit of SWI/SNF complexes.
    Hirano M; Kikuchi Y; Nisitani S; Yamaguchi A; Satoh A; Ito T; Iba H; Takatsu K
    Int Immunol; 2004 May; 16(5):747-57. PubMed ID: 15096481
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Failure to downregulate the BAF53a subunit of the SWI/SNF chromatin remodeling complex contributes to the differentiation block in rhabdomyosarcoma.
    Taulli R; Foglizzo V; Morena D; Coda DM; Ala U; Bersani F; Maestro N; Ponzetto C
    Oncogene; 2014 May; 33(18):2354-62. PubMed ID: 23728344
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cytoplasmic interaction of the tumour suppressor protein hSNF5 with dynamin-2 controls endocytosis.
    Alfonso-Pérez T; Domínguez-Sánchez MS; García-Domínguez M; Reyes JC
    Oncogene; 2014 Jun; 33(23):3064-74. PubMed ID: 23851497
    [TBL] [Abstract][Full Text] [Related]  

  • 56. SMARCA2 Is a Novel Interactor of NSD2 and Regulates Prometastatic
    Chong PSY; Chooi JY; Lim JSL; Toh SHM; Tan TZ; Chng WJ
    Cancer Res; 2021 May; 81(9):2332-2344. PubMed ID: 33602783
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Identification of a core member of the SWI/SNF complex, BAF155/SMARCC1, as a human tumor suppressor gene.
    DelBove J; Rosson G; Strobeck M; Chen J; Archer TK; Wang W; Knudsen ES; Weissman BE
    Epigenetics; 2011 Dec; 6(12):1444-53. PubMed ID: 22139574
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Inactivation of SNF5 cooperates with p53 loss to accelerate tumor formation in Snf5(+/-);p53(+/-) mice.
    DelBove J; Kuwahara Y; Mora-Blanco EL; Godfrey V; Funkhouser WK; Fletcher CD; Van Dyke T; Roberts CW; Weissman BE
    Mol Carcinog; 2009 Dec; 48(12):1139-48. PubMed ID: 19676100
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The long noncoding RNA SChLAP1 promotes aggressive prostate cancer and antagonizes the SWI/SNF complex.
    Prensner JR; Iyer MK; Sahu A; Asangani IA; Cao Q; Patel L; Vergara IA; Davicioni E; Erho N; Ghadessi M; Jenkins RB; Triche TJ; Malik R; Bedenis R; McGregor N; Ma T; Chen W; Han S; Jing X; Cao X; Wang X; Chandler B; Yan W; Siddiqui J; Kunju LP; Dhanasekaran SM; Pienta KJ; Feng FY; Chinnaiyan AM
    Nat Genet; 2013 Nov; 45(11):1392-8. PubMed ID: 24076601
    [TBL] [Abstract][Full Text] [Related]  

  • 60. IRF4 requires ARID1A to establish plasma cell identity in multiple myeloma.
    Bolomsky A; Ceribelli M; Scheich S; Rinaldi K; Huang DW; Chakraborty P; Pham L; Wright GW; Hsiao T; Morris V; Choi J; Phelan JD; Holewinski RJ; Andresson T; Wisniewski J; Riley D; Pittaluga S; Hill E; Thomas CJ; Muppidi J; Young RM
    Cancer Cell; 2024 Jul; 42(7):1185-1201.e14. PubMed ID: 38906156
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.